サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1414538

呼吸器疾患検査の世界市場レポート 2024年

Respiratory Disease Testing Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
呼吸器疾患検査の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

呼吸器疾患検査の市場規模は近年着実に成長しています。2023年の34億2,000万米ドルから2024年には35億8,000万米ドルへと、CAGR4.6％で拡大します。過去の期間に見られた拡大は、環境問題や汚染、タバコ喫煙の流行、職業的呼吸器障害、意識向上キャンペーン、健康教育プログラムなど、さまざまな要因が重なったことに起因しています。さらに、疾病対策に向けた政府の取り組みが、この時期の成長ランドスケープの形成に重要な役割を果たしました。

呼吸器疾患検査の市場規模は、今後数年間で安定した成長が見込まれます。2028年には年間平均成長率（CAGR）4.8％で43億1,000万米ドルに成長します。予測期間の成長は、空気感染呼吸器ウイルスの増加、在宅検査ソリューションの重視、精密医療研究の増加、環境衛生への懸念の持続、早期介入と予防の重視など、いくつかの重要な要因に起因すると考えられます。この期間に予想される注目すべき動向には、ポイントオブケア検査の採用、人工知能（AI）の統合、遠隔モニタリング技術の活用、遠隔医療サービスの拡大、カスタマイズされたバイオマーカーパネルの開発、呼気分析技術の強化が含まれます。

呼吸器疾患の有病率が上昇傾向にあることから、呼吸器疾患検査市場は当面、大幅に拡大する見通しです。呼吸器疾患には、肺、気管支、気管、喉頭、咽頭、鼻腔などの呼吸器系に影響を及ぼす病状が含まれます。呼吸器疾患検査の主な目的は、早期発見と診断、そして迅速な治療と管理です。この積極的なアプローチは、疾患の進行を妨げるだけでなく、感染性呼吸器疾患の感染を抑制し、合併症のリスクを低減するためにも極めて重要です。例えば、2022年9月にNCD Allianceが発表したデータによると、肺がんは世界のがん死亡原因の第1位であり、年間220万人が新たに罹患し、180万人が死亡すると予測されています。慢性呼吸器疾患は、世界で5億5,000万人の成人が罹患し、420万人が死亡し、全体の7％を占めています。したがって、呼吸器疾患の有病率の上昇は、呼吸器疾患検査市場の主要な促進要因です。

タバコの喫煙率の増加は、呼吸器疾患検査市場の成長をさらに促進すると予想されます。タバコ喫煙は、乾燥したタバコの葉を燃やすことで発生する煙を吸い込むことで、呼吸器の健康に大きな影響を与えます。呼吸器疾患検査はタバコ喫煙者のケアに欠かせないものとなり、ヘルスケア専門家が肺機能の経時的変化をモニターできるようになります。このモニタリングは、禁煙努力の効果を評価し、それに応じて治療計画を調整するのに役立ちます。例えば、2023年5月に米国疾病予防管理センターが発表したデータによると、2021年には米国の18歳以上の成人は約2,830万人がたばこを吸っており、約1,600万人の米国人が喫煙に関連した病気を抱えて生活しています。このように、タバコ喫煙の増加は呼吸器疾患検査市場拡大の原動力となっています。

北米は、2023年の呼吸器疾患検査市場で最大の地域でした。アジア太平洋は、予測期間中、世界の呼吸器疾患検査市場で最も急成長する地域となる見込みです。呼吸器疾患検査市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の呼吸器疾患検査市場、検査タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 画像検査
  • 機械的試験
  • 体外診断検査
  • 世界の呼吸器疾患検査市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 肺容積
  • イメージング
  • 肺活量測定
  • ピークフロー
  • 血液ガス
  • その他の製品
  • 世界の呼吸器疾患検査市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 慢性閉塞性肺疾患
  • 肺がん
  • 喘息
  • 結核女性
  • その他の用途
  • 世界の呼吸器疾患検査市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 医師の診療所
  • 臨床検査室
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の呼吸器疾患検査市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の呼吸器疾患検査市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 呼吸器疾患検査市場の競合情勢
  • 呼吸器疾患検査市場の企業プロファイル
    • Medtronic plc
    • Carestream Medical Ltd.
    • Abbott Laboratories
    • Siemens Healthineers AG
    • Koninklijke Philips NV

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r12048

“Respiratory Disease Testing Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on respiratory disease testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for respiratory disease testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The respiratory disease testing market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Test Type: Imaging Tests; Mechanical Tests; In-Vitro Diagnostic Tests
  • 2) By Products: Lung Volume; Imaging; Spirometry; Peak Flow; Blood Gas; Other Products
  • 3) By Application: Chronic Obstructive Pulmonary Disease; Lung Cancer; Asthma; Tuberculosis Female; Other Application
  • 4) By End-User: Hospitals; Physician clinics; Clinical laboratories; Other End-User
  • Companies Mentioned: Medtronic plc; Carestream Medical Ltd.; Abbott Laboratories; Siemens Healthineers AG; Koninklijke Philips N.V.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Respiratory disease testing encompasses the diagnostic process of evaluating various respiratory conditions through physical examinations. This procedure aids in the identification and measurement of lung conditions, assessing the speed at which a patient can exhale air. The results of these tests can assist clinicians in diagnosing respiratory diseases, even before patients exhibit symptoms.

The primary categories of tests involved in respiratory disease testing include imaging tests, mechanical tests, and in-vitro diagnostic tests. Imaging tests constitute a subset of diagnostic procedures that generate detailed images of various bodily regions. These tests utilize products such as lung volume imaging, spirometry, peak flow, blood gas, among others. They find applications in various respiratory conditions such as chronic obstructive pulmonary disease, lung cancer, asthma, and tuberculosis. These tests are typically conducted in hospitals, physician clinics, clinical laboratories, and other healthcare settings.

The respiratory disease testing market research report is one of a series of new reports from The Business Research Company that provides respiratory disease testing market statistics, including respiratory disease testing industry global market size, regional shares, competitors with a respiratory disease testing market share, detailed respiratory disease testing market segments, market trends and opportunities, and any further data you may need to thrive in the respiratory disease testing industry. This respiratory disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The respiratory disease testing market size has grown steadily in recent years. It will grow from $3.42 billion in 2023 to $3.58 billion in 2024 at a compound annual growth rate (CAGR) of 4.6%. The expansion observed during the historical period can be attributed to a confluence of factors, including environmental considerations and pollution, the prevalence of the tobacco smoking epidemic, occupational respiratory hazards, awareness campaigns, and health education programs. Additionally, government initiatives geared towards disease control played a significant role in shaping the growth landscape during this timeframe.

The respiratory disease testing market size is expected to see steady growth in the next few years. It will grow to $4.31 billion in 2028 at a compound annual growth rate (CAGR) of 4.8%. Anticipated growth in the forecast period can be attributed to several key factors, including the rise in airborne respiratory viruses, a heightened emphasis on home-based testing solutions, increased research in precision medicine, persistent environmental health concerns, and a focus on early intervention and prevention. Noteworthy trends expected during this period encompass the adoption of point-of-care testing, the integration of artificial intelligence (AI), the utilization of remote monitoring technologies, the expansion of telehealth services, the development of customized biomarker panels, and the enhancement of breath analysis techniques.

The upward trajectory in the prevalence of respiratory diseases is poised to significantly boost the respiratory disease testing market in the foreseeable future. Respiratory diseases encompass medical conditions affecting the respiratory system, including the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. The primary purpose of respiratory disease testing is early detection and diagnosis, facilitating prompt treatment and management. This proactive approach not only helps impede disease progression but is also crucial for controlling the transmission of infectious respiratory diseases and reducing the risk of complications. For instance, in September 2022, data from the NCD Alliance revealed that lung cancer ranked as the leading cause of global cancer deaths, with an anticipated 2.2 million new cases and 1.8 million fatalities annually. Chronic respiratory disorders affected 550 million adults globally, resulting in 4.2 million deaths, accounting for 7% of the total. Therefore, the rising prevalence of respiratory diseases is a key driver for the respiratory disease testing market.

The growing incidence of tobacco smoking is expected to further propel the growth of the respiratory disease testing market. Tobacco smoking, involving the inhalation of smoke produced by burning dried tobacco leaves, has a significant impact on respiratory health. Respiratory disease testing becomes essential in the care of tobacco smokers, enabling healthcare professionals to monitor changes in lung function over time. This monitoring aids in assessing the effectiveness of smoking cessation efforts and adjusting treatment plans accordingly. For example, data from the Centers for Disease Control and Prevention in May 2023 indicated that approximately 28.3 million adults aged 18 years or older in the U.S. were cigarette smokers, and around 16 million Americans were living with smoking-related diseases in 2021. As such, the growing incidence of tobacco smoking stands as a driving force behind the expansion of the respiratory disease testing market.

Technological advancements are emerging as a prominent trend in the respiratory disease testing market, with major companies focusing on innovative solutions to enhance treatment protocols and elevate patient outcomes. A notable example is Respira Labs, a U.S.-based healthcare technology company, which introduced the AI-powered wearable device, Sylvee, in March 2022. Sylvee, worn as a chest strap, employs artificial intelligence and machine learning algorithms to analyze data from multiple sensors measuring breathing rate, volume, and patterns. This device aids in the early diagnosis and management of conditions such as chronic obstructive pulmonary disease (COPD), asthma, and COVID-19, utilizing advanced AI algorithms to analyze breath sounds and provide real-time feedback on lung function.

Major players in the respiratory disease testing market are actively engaged in developing advanced products, such as pulmonary function testing, to establish a competitive advantage. A case in point is Vitalograph Ltd., a UK-based provider of respiratory diagnostics, which launched the VitaloPFT series in March 2023. This series offers detailed pulmonary function testing options, providing healthcare providers with a cost-effective solution for advanced respiratory diagnostics. Its user-friendly design simplifies the testing process, enhancing accessibility for healthcare professionals.

In January 2023, CAIRE Inc., a prominent U.S.-based medical supply and manufacturing company, completed the acquisition of MGC Diagnostics Holdings for an undisclosed amount. This strategic move is driven by CAIRE Inc.'s objective to expand the scope of its product line, diversify its income streams, and fortify its position as a leading player in the medical technology sector, specifically focusing on respiratory and cardiorespiratory diagnostics. MGC Diagnostics Holdings Inc., the acquired entity, is a U.S.-based medical technology company specializing in offering comprehensive cardiorespiratory diagnostic solutions and respiratory disease testing products.

Major companies operating in the respiratory disease testing market report are Medtronic plc, Carestream Medical Ltd., Abbott Laboratories, Seimens Healthineers AG, Koninklijke Philips N.V., ResMed Inc., Thermo Fisher Scientific Inc., Beckton Dickinson And Company, F. Hoffmann-La Roche Ltd., Nihon Kohden Corporation, GE HealthCare Technologies Inc., Merck And Co. Inc., Fisher And Paykel Healthcare Corporation Limited, Qiagen N.V., Medical Graphics Corporation, COSMED srl, ndd Medizintechnik AG, Vitalograph Ltd., MGC Diagnostics Corporation, Vyaire Medical Inc., Smiths Medical International Ltd., Masimo Corporation, Hamilton Medical AG, Dragerwerk AG & Co. KGaA, Hill-Rom Holdings Inc., OSI Systems Inc., Schiller AG, Baxter International Inc., Nonin Medical Inc., Viasys Healthcare Inc., Natus Medical Incorporated

North America was the largest region in the respiratory disease testing market in 2023. Asia-Pacific is expected to be the fastest growing region in the global respiratory disease testing market during the forecast period. The regions covered in the respiratory disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the respiratory disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The respiratory disease testing market includes revenues earned by entities by providing services such as exhaled nitric oxide tests lung function tests. oxygen therapy, bronchoscopy, ultrasonography, nuclear lung scanning, and pulmonary artery angiography. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Respiratory Disease Testing Market Characteristics

3. Respiratory Disease Testing Market Trends And Strategies

4. Respiratory Disease Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Respiratory Disease Testing Market Size and Growth

  • 5.1. Global Respiratory Disease Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Respiratory Disease Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Respiratory Disease Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Respiratory Disease Testing Market Segmentation

  • 6.1. Global Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Imaging Tests
  • Mechanical Tests
  • In-Vitro Diagnostic Tests
  • 6.2. Global Respiratory Disease Testing Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Lung Volume
  • Imaging
  • Spirometry
  • Peak Flow
  • Blood Gas
  • Other Products
  • 6.3. Global Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chronic Obstructive Pulmonary Disease
  • Lung Cancer
  • Asthma
  • Tuberculosis Female
  • Other Application
  • 6.4. Global Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Physician clinics
  • Clinical laboratories
  • Other End-User

7. Respiratory Disease Testing Market Regional And Country Analysis

  • 7.1. Global Respiratory Disease Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Respiratory Disease Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Respiratory Disease Testing Market

  • 8.1. Asia-Pacific Respiratory Disease Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Respiratory Disease Testing Market

  • 9.1. China Respiratory Disease Testing Market Overview
  • 9.2. China Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Respiratory Disease Testing Market

  • 10.1. India Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Respiratory Disease Testing Market

  • 11.1. Japan Respiratory Disease Testing Market Overview
  • 11.2. Japan Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Respiratory Disease Testing Market

  • 12.1. Australia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Respiratory Disease Testing Market

  • 13.1. Indonesia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Respiratory Disease Testing Market

  • 14.1. South Korea Respiratory Disease Testing Market Overview
  • 14.2. South Korea Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Respiratory Disease Testing Market

  • 15.1. Western Europe Respiratory Disease Testing Market Overview
  • 15.2. Western Europe Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Respiratory Disease Testing Market

  • 16.1. UK Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Respiratory Disease Testing Market

  • 17.1. Germany Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Respiratory Disease Testing Market

  • 18.1. France Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Respiratory Disease Testing Market

  • 19.1. Italy Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Respiratory Disease Testing Market

  • 20.1. Spain Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Respiratory Disease Testing Market

  • 21.1. Eastern Europe Respiratory Disease Testing Market Overview
  • 21.2. Eastern Europe Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Respiratory Disease Testing Market

  • 22.1. Russia Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Respiratory Disease Testing Market

  • 23.1. North America Respiratory Disease Testing Market Overview
  • 23.2. North America Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Respiratory Disease Testing Market

  • 24.1. USA Respiratory Disease Testing Market Overview
  • 24.2. USA Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Respiratory Disease Testing Market

  • 25.1. Canada Respiratory Disease Testing Market Overview
  • 25.2. Canada Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Respiratory Disease Testing Market

  • 26.1. South America Respiratory Disease Testing Market Overview
  • 26.2. South America Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Respiratory Disease Testing Market

  • 27.1. Brazil Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Respiratory Disease Testing Market

  • 28.1. Middle East Respiratory Disease Testing Market Overview
  • 28.2. Middle East Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Respiratory Disease Testing Market

  • 29.1. Africa Respiratory Disease Testing Market Overview
  • 29.2. Africa Respiratory Disease Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Respiratory Disease Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Respiratory Disease Testing Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Respiratory Disease Testing Market Competitive Landscape And Company Profiles

  • 30.1. Respiratory Disease Testing Market Competitive Landscape
  • 30.2. Respiratory Disease Testing Market Company Profiles
    • 30.2.1. Medtronic plc
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Carestream Medical Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Siemens Healthineers AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Koninklijke Philips N.V
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Respiratory Disease Testing Market Competitive Benchmarking

32. Global Respiratory Disease Testing Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Respiratory Disease Testing Market

34. Respiratory Disease Testing Market Future Outlook and Potential Analysis

  • 34.1 Respiratory Disease Testing Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Respiratory Disease Testing Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Respiratory Disease Testing Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer